Novo Slides; Accenture Up; Arhaus Upgrade | Stock Movers
Community Score: 50% | 32 views | 3w
0 community ratings: null thumbs up, null thumbs down
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news. Arhaus (ARHS) is moving after Jefferies upgraded the furniture company to buy from hold, writing that it has “newfound optimism on the retailer’s strategy to elevate brand awareness” and improve market share. Accenture (ACN) is up on news Anthropic is partnering with Accenture to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Bloo
Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast
More from Bloomberg Podcasts
- Follow the Money All the Way to Carney's Canada — Score: 50%
- Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
- Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
- We hear you! | Bloomberg Hot Pursuit! — Score: 50%
- Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
- Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%